High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma

Completed · Phase 2

Conditions studied: Lymphoma, Non-Hodgkin, Blood and Marrow Transplant (BMT), Lymphomas: Non-Hodgkin

In brief

To evaluate the role of allogeneic hematopoietic cell transplantation in the treatment of NHL.

Key facts

Study ID

NCT00186394

Run by

Stanford University

People needed

35

Starts

2000-04-01

Expected to finish

2006-12-01

Last updated by the study team

2010-07-27

Who can join

Age: 18 and older, up to 61. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.